GPCR
Price
$73.20
Change
-$8.06 (-9.92%)
Updated
Feb 5, 04:59 PM (EDT)
Capitalization
5.74B
49 days until earnings call
Intraday BUY SELL Signals
IMVT
Price
$24.04
Change
-$1.11 (-4.41%)
Updated
Feb 5, 04:59 PM (EDT)
Capitalization
5.07B
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GPCR vs IMVT

Header iconGPCR vs IMVT Comparison
Open Charts GPCR vs IMVTBanner chart's image
Structure Therapeutics
Price$73.20
Change-$8.06 (-9.92%)
Volume$41.65K
Capitalization5.74B
Immunovant
Price$24.04
Change-$1.11 (-4.41%)
Volume$81K
Capitalization5.07B
GPCR vs IMVT Comparison Chart in %
GPCR
Daily Signal:
Gain/Loss:
IMVT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GPCR vs. IMVT commentary
Feb 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GPCR is a Hold and IMVT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 06, 2026
Stock price -- (GPCR: $81.26 vs. IMVT: $25.15)
Brand notoriety: GPCR and IMVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GPCR: 59% vs. IMVT: 113%
Market capitalization -- GPCR: $5.74B vs. IMVT: $5.07B
GPCR [@Biotechnology] is valued at $5.74B. IMVT’s [@Biotechnology] market capitalization is $5.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GPCR’s FA Score shows that 0 FA rating(s) are green whileIMVT’s FA Score has 0 green FA rating(s).

  • GPCR’s FA Score: 0 green, 5 red.
  • IMVT’s FA Score: 0 green, 5 red.
According to our system of comparison, both GPCR and IMVT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GPCR’s TA Score shows that 4 TA indicator(s) are bullish while IMVT’s TA Score has 4 bullish TA indicator(s).

  • GPCR’s TA Score: 4 bullish, 4 bearish.
  • IMVT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both GPCR and IMVT are a good buy in the short-term.

Price Growth

GPCR (@Biotechnology) experienced а -8.75% price change this week, while IMVT (@Biotechnology) price change was -3.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.81%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was +30.06%.

Reported Earning Dates

GPCR is expected to report earnings on Mar 26, 2026.

IMVT is expected to report earnings on Feb 06, 2026.

Industries' Descriptions

@Biotechnology (-5.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($5.74B) has a higher market cap than IMVT($5.07B). GPCR YTD gains are higher at: 16.837 vs. IMVT (-1.062). GPCR has higher annual earnings (EBITDA): -246.42M vs. IMVT (-486.69M). GPCR has more cash in the bank: 799M vs. IMVT (522M). IMVT has less debt than GPCR: IMVT (98K) vs GPCR (7.09M). GPCR (0) and IMVT (0) have equivalent revenues.
GPCRIMVTGPCR / IMVT
Capitalization5.74B5.07B113%
EBITDA-246.42M-486.69M51%
Gain YTD16.837-1.062-1,585%
P/E RatioN/AN/A-
Revenue00-
Total Cash799M522M153%
Total Debt7.09M98K7,235%
FUNDAMENTALS RATINGS
IMVT: Fundamental Ratings
IMVT
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GPCRIMVT
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 7 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
GPCR
Daily Signal:
Gain/Loss:
IMVT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPNNX6.220.05
+0.77%
Invesco SteelPath MLP Income R
TEMIX33.690.20
+0.60%
Franklin Mutual International Value A
ZGFIX18.87-0.07
-0.37%
American Beacon Ninety One Gbl Frnchs R5
REEBX62.13-0.37
-0.59%
American Funds EUPAC R2E
MELIX17.43-0.28
-1.58%
Morgan Stanley Inst EMkts Ldrs I

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been closely correlated with ATOS. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if GPCR jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
-3.01%
ATOS - GPCR
80%
Closely correlated
-4.34%
PHGE - GPCR
77%
Closely correlated
-7.36%
PMN - GPCR
77%
Closely correlated
-1.57%
CANF - GPCR
74%
Closely correlated
-0.25%
ANL - GPCR
73%
Closely correlated
+7.23%
More

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been closely correlated with COGT. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMVT jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
-2.52%
COGT - IMVT
71%
Closely correlated
-1.15%
RVMD - IMVT
69%
Closely correlated
+0.56%
SYRE - IMVT
66%
Loosely correlated
-3.66%
VRDN - IMVT
66%
Loosely correlated
-4.80%
GPCR - IMVT
65%
Loosely correlated
-3.01%
More